Literature DB >> 12355677

Mental retardation in teenagers: prevalence data from the Niagara region, Ontario.

Elspeth A Bradley1, Ann Thompson, Susan E Bryson.   

Abstract

OBJECTIVES: There are few Canadian prevalence studies of mental retardation (MR); those that do exist were conducted prior to the era of community integration. We undertook a population-based study to explore mental health disturbances in young persons with MR. The first requirement was to identify a population with MR and to establish its prevalence. Here, we report data on the prevalence of MR in a population aged 14 to 20 years.
METHOD: We conducted the study in the Niagara Region of Ontario, which has a population base of around 400,000. Researchers worked closely with schools and with agencies providing services to persons with MR to identify the study group. We confirmed the functioning level of participants through standard tests of nonverbal intelligence and receptive language; teachers and other service personnel provided information relevant to the estimation of nonparticipants' functioning level.
RESULTS: We identified 255 individuals as having MR (IQ < or = 75). Of these, 171 chose to participate (defined as "participants with MR"; the remaining 84 were "nonparticipants with MR"). Thus, the participation rate was 67% (171/255). Participants and nonparticipants with MR did not differ on age, sex, or IQ, although there were more nonparticipants in the lower social strata. Overall prevalence for MR was 7.18/1000. For mild mental retardation (MMR; that is, IQ = 50 to 75), prevalence was 3.54/1000, and for severe mental retardation (SMR; that is, IQ < 50), it was 3.64/1000.
CONCLUSIONS: Our prevalence estimate for SMR is similar to rates from previous studies conducted worldwide. Our estimate for MMR parallels the lower rates found in Scandinavian countries and contrasts with the higher rates generally reported in the US.

Entities:  

Mesh:

Year:  2002        PMID: 12355677     DOI: 10.1177/070674370204700707

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  7 in total

1.  Consensus guidelines for primary health care of adults with developmental disabilities.

Authors:  William F Sullivan; John Heng; Donna Cameron; Yona Lunsky; Tom Cheetham; Brian Hennen; Elspeth A Bradley; Joseph M Berg; Marika Korossy; Cynthia Forster-Gibson; Maria Gitta; Chrissoula Stavrakaki; Bruce McCreary; Irene Swift
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

2.  A Review of Global Literature on Using Administrative Data to Estimate Prevalence of Intellectual and Developmental Disabilities.

Authors:  Daniel J Friedman; R Gibson Parrish; Michael H Fox
Journal:  J Policy Pract Intellect Disabil       Date:  2018-01-26

3.  Epilepsy among children and adolescents with autism spectrum disorders: a population-based study.

Authors:  Elina Jokiranta; Andre Sourander; Auli Suominen; Laura Timonen-Soivio; Alan S Brown; Matti Sillanpää
Journal:  J Autism Dev Disord       Date:  2014-10

4.  Medical students' views on training in intellectual disabilities.

Authors:  Philip Burge; Hélène Ouellette-Kuntz; Barry Isaacs; Yona Lunsky
Journal:  Can Fam Physician       Date:  2008-04       Impact factor: 3.275

5.  Comparing rates of psychiatric and behavior disorders in adolescents and young adults with severe intellectual disability with and without autism.

Authors:  Elspeth A Bradley; Jane A Summers; Hayley L Wood; Susan E Bryson
Journal:  J Autism Dev Disord       Date:  2004-04

6.  The genetic basis of non-syndromic intellectual disability: a review.

Authors:  Liana Kaufman; Muhammad Ayub; John B Vincent
Journal:  J Neurodev Disord       Date:  2010-07-29       Impact factor: 4.025

7.  Socio demography of mental retardation: A community-based study from a goitre zone in rural sub-Himalayan India.

Authors:  Shailja Sharma; Sunil Kumar Raina; Ashok Kumar Bhardwaj; Sanjeev Chaudhary; Vipasha Kashyap; Vishav Chander
Journal:  J Neurosci Rural Pract       Date:  2015 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.